Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2024-09-18 00:00:00 ET · period of report 2024-07-11 · accession 0001628280-24-040832 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-09-18 | 2024-07-11+ | BLFS | Mathew Aby J. | EVP, CSO | S - Sale | $23.32 | -767 | 317.7K | -0.2% | -$17.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-11 | S | D | 313 | $20.54 | 318,170 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-21 | S | D | 111 | $25.61 | 318,059 | D | — | — | |
| 3 | Common | Common Stock | 2024-09-16 | S | D | 343 | $25.12 | 317,716 | D | — | — |